Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 653-661 , August 2007

Quantitative assessment of rheumatoid arthritis in standard clinical care: turning clinical care into clinical science

  • Tuulikki Sokka, MD, PhD (Consulting Rheumatologist)

      Affiliations

    • Corresponding Author InformationTel.: +358 40 735 2087; Fax: +358 14 2691 275.

References 

  1. Smith T. Questions on clinical trials (editorial). British Medical Journal. 1983;287:569
  2. Isomäki HA, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology. 1975;4:205–208
  3. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis and Rheumatism. 1984;27:864–872
  4. Wilske KR, Healey LA. Remodeling the pyramid – a concept whose time has come. The Journal of Rheumatology. 1989;16:565–567
  5. Pincus T. Rheumatoid arthritis: a medical emergency?. Scandinavian Journal of Rheumatology. 1994;23(supplement 100):21–30
  6. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission?. Annals of the Rheumatic Diseases. 1995;54:944–947
  7. Weinblatt ME. Rheumatoid arthritis: treat now, not later! (editorial). Annals of Internal Medicine. 1996;124:773–774
  8. Luukkainen R, Kajander A, Isomäki H. Treatment of rheumatoid arthritis (letter). British Medical Journal. 1978;2:1501
  9. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. The Journal of Rheumatology. 1994;21:1227–1237
  10. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. The Journal of Rheumatology. 2003;30(6):1138–1146
  11. Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clinical and Experimental Rheumatology. 2003;21:S146–S153
  12. Pincus T, Brooks RH, Callahan LF. A proposed standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes. The Journal of Rheumatology. 1999;26:473–480
  13. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. The New England Journal of Medicine. 2000;343:1586–1593
  14. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis and Rheumatism. 2002;46(6):1443–1450
  15. Sokka T, Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis and Rheumatism. 2003;48(2):313–318
  16. St Clair EW, Wagner CL, Fasanmade AA, et al. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism. 2002;46(6):1451–1459
  17. Pincus T, Sokka T, Chung CP, Cawkwell G. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials. Annals of the Rheumatic Diseases. 2006;65:878–883
  18. Gogus F, Yazici Y, Yazici H. Inclusion criteria as widely used for rheumatoid arthritis clinical trials: patient eligibility in a Turkish cohort. Clinical and Experimental Rheumatology. 2005;23(5):681–684
  19. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis and Rheumatism. 2005;52:1009–1019
  20. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the ‘sawtooth’ strategy. The Journal of Rheumatology. 1990;17(supplement 22):12–15
  21. Ward MM. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980–1995: results from the national ambulatory medical care surveys. The Journal of Rheumatology. 1999;26:546–550
  22. Pincus T, Yazici Y, Sokka T, et al. Methotrexate as the ‘anchor drug’ for the treatment of early rheumatoid arthritis. Clinical and Experimental Rheumatology. 2003;21:S179–S185
  23. Klaukka T, Kaarela K. Methotrexate is the leading DMARD in Finland. Annals of the Rheumatic Diseases. 2003;62:494–496
  24. Sokka T, Pincus T. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. The Journal of Rheumatology. 2002;29(12):2521–2524
  25. Sokka T, Hetland ML, Verstappen SMM, et al. Current use of biologics and other DMARDs in a sample of 1579 patients with rheumatoid arthritis receiving routine clinical care in 9 Western European countries. Annals of the Rheumatic Diseases. 2006;65:(Abstract)
  26. Sokka T, Kautiainen H, Häkkinen K, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. The Journal of Rheumatology. 2004;31:1073–1082
  27. Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003 – An indication of improved long-term outcomes of rheumatoid arthritis?. Annals of the Rheumatic Diseases. 2007;66:341–344
  28. Sokka T. National databases and rheumatology research I: longitudinal databases in Scandinavia. Rheumatic Diseases Clinics of North America. 2004;30(4):851–867
  29. Sokka T, Krishnan E, Häkkinen A, Hannonen P. Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis and Rheumatism. 2003;48(1):59–63
  30. Pincus T, Sokka T. Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses?. The Journal of Rheumatology. 2001;28:1723–1734
  31. Sokka T, Hakkinen A, Krishnan E, Hannonen P. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Annals of the Rheumatic Diseases. 2004;63:494–497
  32. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. The American journal of Cardiology. 1996;78(8):890–895
  33. Justice AC, Aiken LH, Smith HL, Turner BJ. The role of functional status in predicating inpatient mortality with AIDS: a comparison with current predictors. Journal of Clinical Epidemiology. 1996;49:193–201
  34. Cunningham WE, Crystal S, Bozzette S, Hays RD. The association of health-related quality of life with survival among persons with HIV infection in the United States. Journal of General Internal Medicine. 2005;20(1):21–27
  35. Yelin E, Meenan R, Nevitt M, Epstein W. Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Annals of Internal Medicine. 1980;93:551–556
  36. Mäkisara GL, Mäkisara P. Prognosis of functional capacity and work capacity in rheumatoid arthritis. Clinical Rheumatology. 1982;1:117–125
  37. Chung CP, Sokka T, Arbogast P, Pincus T. Work disability in rheumatoid arthritis: differences in patients with early disease in Finland and the United States. Annals of the Rheumatic Diseases. 2006;65:1653–1657
  38. Sokka T, Makinen H, Hetland ML, et al. A multi-national cross-sectional database to assess clinical status of patients with rheumatoid arthritis (QUEST-RA). Scandinavian Journal of Rheumatology. 2006;35(Supplement 121):32–33(Abstract)
  39. Sokka T, Verstappen SMM, Hetland ML, et al. Work disability in patients with rheumatoid arthritis in 15 countries. Arthritis and Rheumatism. 2006;54(9 (Supplement)):(Abstract)
  40. Sokka T, Kautiainen H, Gossec L, et al. Does poor functional capacity prevent RA patients from physical exercises?. Arthritis and Rheumatism. 2006;54(9(Supplement)):(Abstract)

PII: S1521-6942(07)00003-4

doi: 10.1016/j.berh.2007.01.002

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 653-661 , August 2007

Article Tools